Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
191.86
-3.60 (-1.84%)
At close: Mar 27, 2026, 4:00 PM EDT
192.19
+0.33 (0.17%)
After-hours: Mar 27, 2026, 7:11 PM EDT
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 20 analysts that cover Tenet Healthcare stock have a consensus rating of "Buy" and an average price target of $237.9, which forecasts a 24.00% increase in the stock price over the next year. The lowest target is $154 and the highest is $288.
Price Target: $237.9 (+24.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Tenet Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 7 | 7 |
| Buy | 10 | 10 | 10 | 10 | 11 | 11 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $271 → $283 | Strong Buy | Maintains | $271 → $283 | +47.50% | Mar 12, 2026 |
| Mizuho | Mizuho | Buy Maintains $235 → $265 | Buy | Maintains | $235 → $265 | +38.12% | Mar 12, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $255 → $264 | Buy | Maintains | $255 → $264 | +37.60% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $240 → $270 | Strong Buy | Maintains | $240 → $270 | +40.73% | Feb 17, 2026 |
| Barclays | Barclays | Buy Maintains $240 → $257 | Buy | Maintains | $240 → $257 | +33.95% | Feb 13, 2026 |
Financial Forecast
Revenue This Year
22.24B
from 21.31B
Increased by 4.36%
Revenue Next Year
22.66B
from 22.24B
Increased by 1.88%
EPS This Year
17.15
from 15.49
Increased by 10.74%
EPS Next Year
17.82
from 17.15
Increased by 3.88%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.3B | 24.6B | |||
| Avg | 22.2B | 22.7B | |||
| Low | 21.4B | 21.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.2% | 10.4% | |||
| Avg | 4.4% | 1.9% | |||
| Low | 0.6% | -4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 19.24 | 21.36 | |||
| Avg | 17.15 | 17.82 | |||
| Low | 11.49 | 14.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.2% | 24.5% | |||
| Avg | 10.7% | 3.9% | |||
| Low | -25.9% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.